share_log

JonesTrading Initiates Coverage On Cullinan Oncology With Buy Rating, Announces Price Target of $22

JonesTrading Initiates Coverage On Cullinan Oncology With Buy Rating, Announces Price Target of $22

JoneStrading以買入評級開始對Cullinan Oncology進行報道,宣佈目標股價爲22美元
Benzinga ·  2023/10/06 05:50

JonesTrading analyst Soumit Roy initiates coverage on Cullinan Oncology (NASDAQ:CGEM) with a Buy rating and announces Price Target of $22.

瓊恩斯交易分析師Soumit Roy以買入評級啟動對庫利南腫瘤學(納斯達克:CGEM)的報道,並宣佈目標價為22美元。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論